Wolters Kluwer Health Acquires Leading Open Access STM Journal Publisher in India

12/5/2011, 3:30 PM (Source: GlobeNewswire)
Acquisition Gives Wolters Kluwer Health Strong Foothold in Open Access
Publishing Business

Philadelphia, Pa. (December 5, 2011) - Wolters Kluwer Health today announced
that it has acquired Medknow PVT Ltd., a leading Scientific, Technical & Medical
(STM) journal publishing operation headquartered in Mumbai, India and one of the
largest open access publishers in the world. The acquisition expands Wolters
Kluwer Health's Medical Research business' presence in key developing markets
and supports its strategy to increase locally written content and incorporate
more open access platforms into its business model. Terms of the deal were not

"Research is changing in the developing world with clinicians and researchers
looking for more access to locally-written content that is peer-reviewed and
accessible via open platforms," said Karen Abramson, President & CEO, Wolters
Kluwer Health, Medical Research. "Our acquisition of Medknow aligns with our
strategy of continuing to invest in providing the latest, most trusted
information to our customers around the world to help them fuel discoveries and
enhance patient care."

Founded in 1977, Medknow has a strong portfolio of more than 155 journals and
offers much of its content electronically. The company has strong market share
among journals published in India and also has a growing presence in Asia
Pacific and the MEA region. In addition to its print and electronic journal
content, the company provides an electronic peer-review system for authors and
editors, ensuring high quality clinical research. The deal will enable Wolters
Kluwer Health to accelerate advances in the open access arena. It also furthers
the company's growth strategy of continued investment in international expansion
in key emerging markets across the globe.

For Wolters Kluwer Health customers, the deal means expanded access to medical
content in more markets around the world. Medknow's journals will join an
extensive portfolio of nearly 300 practitioner journals, including those which
are published by Wolters Kluwer Health's Lippincott Williams & Wilkins brand and
additional journals made available through our society partnerships. There will
also be opportunities via Wolters Kluwer Health's Ovid brand, which is the
online source for the latest electronic research information used by the world's
leading universities, academic research libraries, hospitals and pharmaceutical
companies, among others.

For more information on Wolters Kluwer Health, visit
www.wolterskluwerhealth.com. For more information on Medknow, visit

About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information
and business intelligence for students, professionals and institutions in
medicine, nursing, allied health and pharmacy. Major brands include traditional
publishers of medical and drug reference tools and textbooks, such asLippincott
Williams & Wilkins and Facts & Comparisons(®); and electronic information
providers, such as Ovid(®), UpToDate(®), Medi-Span(®), Pharmacy OneSource and
ProVation(®) Medical.

Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global
information services company. Professionals in the areas of legal, business,
tax, accounting, finance, audit, risk, compliance, and healthcare rely on
Wolters Kluwer's leading, information-enabled tools and solutions to manage
their business efficiently, deliver results to their clients, and succeed in an
ever more dynamic world.

Wolters Kluwer has 2010 annual revenues of €3.6 billion ($4.7 billion), employs
approximately 19,300 people worldwide, and maintains operations in over 40
countries across Europe, North America, Asia Pacific, and Latin America. Wolters
Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are
quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100

Forward-looking Statements
This press release contains forward-looking statements. These statements may be
identified by words such as "expect", "should", "could", "shall", and similar
expressions. Wolters Kluwer cautions that such forward-looking statements are
qualified by certain risks and uncertainties that could cause actual results and
events to differ materially from what is contemplated by the forward-looking
statements. Factors which could cause actual results to differ from these
forward-looking statements may include, without limitation, general economic
conditions; conditions in the markets in which Wolters Kluwer is engaged;
behavior of customers, suppliers, and competitors; technological developments;
the implementation and execution of new ICT systems or outsourcing; and legal,
tax, and regulatory rules affecting Wolters Kluwer's businesses, as well as
risks related to mergers, acquisitions, and divestments. In addition, financial
risks such as currency movements, interest rate fluctuations, liquidity, and
credit risks could influence future results. The foregoing list of factors
should not be construed as exhaustive. Wolters Kluwer disclaims any intention or
obligation to publicly update or revise any forward-looking statements, whether
as a result of new information, future events, or otherwise.

|Contact:|Robert Dekker |Jon Teppo |
| |Vice President, Communications |Vice President, Investor Relations|
| |Wolters Kluwer Health |Wolters Kluwer |
|  |+1 (215) 521-8928 |+ 31 (0)172 641 407 |
|  |robert.dekker@wolterskluwer.com|ir@wolterskluwer.com |

PDF version of Press Release:

This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Wolters Kluwer NV via Thomson Reuters ONE

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.